Medspero Pharma (MSP) is a first-in-class pharmaceutical company specialized in in-licensing, acquiring, registering and commercializing FDA, EMA/European and Japanese PMDA approved products to address the unmet medical needs of diseases with high regional prevalence in the Middle East and North Africa (MENA) region.
Started its business in 2011, since then we have managed to grow rapidly, make partnerships and grab attention of new partners.
Medspero's innovative business model and efficient commercialization engine is built by successful and respected industry leaders with strong local and international track records.
In addition, the MSP team has competencies in areas of registration, medical, pharmacovigilance and commercial capabilities acquired through years of experience in multinational pharma.
The team is also well-connected to a wide range of partners and key stakeholders in and out of the region, and offers a flexible approach to joint-ventures and partnerships.
This integrated and unique strategy of regional expertise and strong international access makes MSP the partner-of-choice, offering a one-stop-innovative model for pharmaceutical, biotechnology and other healthcare companies seeking to access the rapidly expanding markets of the MENA region.